Articles tagged with: PLX4032

Roche’s New Therapy Prolongs Life of Melanoma Patients

Roche’s New Therapy Prolongs Life of Melanoma Patients

New Therapy Prolongs Life of Melanoma Patients Roche has announced promising results for their Phase 3 clinical study (the BRIM3 trial) of the targeted anticancer drug PLX4032 in patients with previously untreated melanoma that has spread throughout the body.